Sakar Healthcare Limited (NSE:SAKAR)
India · Delayed Price · Currency is INR 892.80
+48.40 (5.73%)
Jul 31, 2026, 3:30 PM IST
Sakar Healthcare Market Cap
Sakar Healthcare has a market cap or net worth of 19.7 billion as of July 31, 2026. Its market cap has increased by 160.53% in one year.
Market Cap
19.70B
Enterprise Value
20.40B
Revenue
2.72B
Ranking
n/a
PE Ratio
54.64
Stock Price
892.80
ChartMarket Cap Chart
Since October 11, 2017, Sakar Healthcare's market cap has increased from 560.11M to 19.70B, an increase of 3,416.60%. That is a compound annual growth rate of 49.81%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 19.70B | 116.34% |
| Dec 31, 2025 | 9.10B | 41.21% |
| Dec 31, 2024 | 6.45B | -15.35% |
| Dec 29, 2023 | 7.62B | 82.44% |
| Dec 30, 2022 | 4.18B | 49.95% |
| Dec 31, 2021 | 2.78B | 89.41% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Oct 11, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aarti Pharmalabs | 60.48B |
| Innova Captab | 55.75B |
| Orchid Pharma | 50.04B |
| RPG Life Sciences | 45.95B |
| Solara Active Pharma Sciences | 24.74B |
| Beta Drugs | 22.53B |
| Indoco Remedies | 20.26B |
| Ind-Swift Laboratories | 19.45B |